Chikungunya: First Steps toward Specific Treatment and Prophylaxis

Michault, Alain; Staikowsky, F.
August 2009
Journal of Infectious Diseases;8/15/2009, Vol. 200 Issue 4, p489
Academic Journal
The author reflects on the study conducted by Couderc and his colleagues that focuses on the treatment and prophylaxia of Chikungunya (CHIKV). He defines the pathology of Chikungunya. He stresses that the study of Couderc and his colleagues is a promising first step toward developing successful specific treatment and prophylaxis for severe cases of Chikungunya for they had obtained a polyvalent immunoglobulins G with anti-CHIKV neutralizing activity (CHIKVIg) to treat immunocompromised patients.


Related Articles

  • Now, A Vaccine for Chikungunya.  // India -- West;9/2/2011, Vol. 36 Issue 41, pA31 

    The article reports on the vaccine developed by scientists in the U.S. against chikungunya, a mosquito-borne virus that affects millions of people in India.

  • A Model for a Chikungunya Outbreak in a Rural Cambodian Setting: Implications for Disease Control in Uninfected Areas. Robinson, Marguerite; Conan, Anne; Duong, Veasna; Ly, Sowath; Ngan, Chantha; Buchy, Philippe; Tarantola, Arnaud; Rodó, Xavier // PLoS Neglected Tropical Diseases;Sep2014, Vol. 8 Issue 9, p1 

    Following almost 30 years of relative silence, chikungunya fever reemerged in Kenya in 2004. It subsequently spread to the islands of the Indian Ocean, reaching Southeast Asia in 2006. The virus was first detected in Cambodia in 2011 and a large outbreak occurred in the village of Trapeang Roka...

  • Chikungunya: an overview. Sudeep, A. B.; Parashar, D. // Journal of Biosciences;Nov2008, Vol. 33 Issue 4, p443 

    Chikungunya (CHIK), a mosquito borne debilitating disease, is caused by CHIK virus, an alphavirus belonging to the family Togaviridae. The sudden onset of very high fever along with rash, and severe arthralgia especially in the small joints of hands and toes are the characteristics of the...

  • Rapid and Long-Term Immunity Elicited by DNA-Encoded Antibody Prophylaxis and DNA Vaccination Against Chikungunya Virus. Muthumani, Karuppiah; Block, Peter; Flingai, Seleeke; Muruganantham, Nagarajan; Chaaithanya, Itta Krishna; Tingey, Colleen; Wise, Megan; Reuschel, Emma L.; Chung, Christopher; Muthumani, Abirami; Sarangan, Gopalsamy; Srikanth, Padma; Khan, Amir S.; Vijayachari, Paluru; Sardesai, Niranjan Y.; Kim, J. Joseph; Ugen, Kenneth E.; Weiner, David B. // Journal of Infectious Diseases;8/1/2016, Vol. 214 Issue 3, p369 

    Background: Vaccination and passive antibody therapies are critical for controlling infectious diseases. Passive antibody administration has limitations, including the necessity for purification and multiple injections for efficacy. Vaccination is associated with a lag phase before...

  • Knowledge, Attitude and Practices of Vector-Borne Disease Prevention during the Emergence of a New Arbovirus: Implications for the Control of Chikungunya Virus in French Guiana. Fritzell, Camille; Raude, Jocelyn; Adde, Antoine; Dusfour, Isabelle; Quenel, Philippe; Flamand, Claude // PLoS Neglected Tropical Diseases;11/1/2016, Vol. 10 Issue 10, p1 

    Background: During the last decade, French Guiana has been affected by major dengue fever outbreaks. Although this arbovirus has been a focus of many awareness campaigns, very little information is available about beliefs, attitudes and behaviors regarding vector-borne diseases among the...

  • Chikungunya. Hamer, Davidson H.; Lin H. Chen // Annals of Internal Medicine;4/7/2015, Vol. 162 Issue 7, p532 

    A response from the author of the article "Chikungunya: establishing a new home in the Western hemisphere" that appeared in a 2014 issue of the journal is presented.

  • Erratum.  // Emerging Infectious Diseases;Aug2009, Vol. 15 Issue 8, p1334 

    A correction to the article "Coordinated Implementation of Chikungunya Virus Reverse Transcription-PCR" that was published in Volume 15, Number 3 of "Emerging Infectious Diseases," is presented.

  • Loss of Glycosaminoglycan Receptor Binding after Mosquito Cell Passage Reduces Chikungunya Virus Infectivity. Acharya, Dhiraj; Paul, Amber M.; Anderson, John F.; Huang, Faqing; Bai, Fengwei // PLoS Neglected Tropical Diseases;10/20/2015, Vol. 9 Issue 10, p1 

    Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that can cause fever and chronic arthritis in humans. CHIKV that is generated in mosquito or mammalian cells differs in glycosylation patterns of viral proteins, which may affect its replication and virulence. Herein, we compare...

  • Prophylaxis and Therapy for Chikungunya Virus Infection. Couderc, Thérèse; Khandoudi, Nassirah; Grandadam, Marc; Visse, Catherine; Gangneux, Nicolas; Bagot, Sébastien; Prost, Jean-François; Lecuit, Marc // Journal of Infectious Diseases;8/15/2009, Vol. 200 Issue 4, p516 

    Background. Chikungunya virus (CHIKV) is a recently reemerged arbovirus responsible for amassive outbreak of infection in the Indian Ocean region and India that has a very significant potential to spread globally because of the worldwide distribution of its mosquito vectors. CHIKV induces a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics